MedTrace Logo

Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach

NCT05829824 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2026-02-13

No results posted yet for this study

Summary

This is a multi-arm, randomized controlled, pilot study which will recruit cancer patients who have been seen by a UCSF Cancer Center-affiliated clinical department to evaluate the efficacy of "CareConnect". This is the first study to assess the efficacy CareConnect, a combination of the Ask-Advise-Connect (AAC) with an Interactive Voice Response (IVR) delivering cancer-targeted educational messages to support referral to smoking cessation resources for patients with cancer.

Conditions

  • Cancer
  • Tobacco Dependence
  • Tobacco Use Cessation

Interventions

BEHAVIORAL

CareConnect

A combination of the Ask-Advise-Connect (AAC) with an Interactive Voice Response (IVR)

OTHER

AutoReach

Phone call / SMS Text

PROCEDURE

Biospecimen samples

Optional saliva sample

Sponsors & Collaborators

Principal Investigators

  • Janice Tsoh, PhD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-27
Primary Completion
2025-05-07
Completion
2025-08-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05829824 on ClinicalTrials.gov